首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1673643

神经血管导管市场规模、份额及成长分析（按类型、组件、应用、最终用途和地区）－2025-2032 年产业预测

Neurovascular Catheters Market Size, Share, and Growth Analysis, By Type (Microcatheters, Balloon Catheters), By Component (Catheter Mandrels, Catheter Liners), By Application, By End-use, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年神经血管导管市场规模为 32.5 亿美元，预计将从 2024 年的 34.8 亿美元成长到 2032 年的 60.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.2%。

根据市场洞察，脑动脉瘤和中风等神经系统疾病的增加、不健康的生活方式选择以及公众对治疗方案的认识不断提高，正在推动神经血管领域的强劲增长。全球蛛网膜下腔出血（SAH）的发生率约为每十万人 6.67 人，每年影响超过 50 万人，主要发生在中低收入地区。此外，技术进步，尤其是神经血管导管技术的进步，正在推动市场扩张。特别是，Serenovas于2022年2月推出了EMBOGUARD血管内治疗导管，以增强急性缺血性脑中风的治疗效果。随着调查方法不断证实各种神经血管通路技术的安全性和有效性，为创新解决方案铺路预计将在预测期内推动市场成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Medtronic（Galway, Ireland）
Boston Scientific（Marlborough, Massachusetts, USA）
Stryker Corporation（Kalamazoo, Michigan, USA）
Penumbra（Alameda, California, USA）
Edwards Lifesciences（Irvine, California, USA）
Terumo Corporation（Tokyo, Japan）
Johnson & Johnson（New Brunswick, New Jersey, USA）
Abbott Laboratories（Abbott Park, Illinois, USA）
B. Braun Melsungen（Melsungen, Germany）
MicroPort Scientific（Shanghai, China）
Integer Holdings Corporation（Plano, Texas, USA）
Cook Medical（Bloomington, Indiana, USA）
Cardinal Health（Dublin, Ohio, USA）
Smith & Nephew（London, United Kingdom）
Teleflex Incorporated（Wayne, Pennsylvania, USA）
Merit Medical Systems（South Jordan, Utah, USA）
Nipro Corporation（Osaka, Japan）
Asahi Intecc（Aichi, Japan）
WL Gore & Associates（Newark, Delaware, USA）
Convatec（London, United Kingdom）

结论和建议

简介目录

Product Code: SQMIG35A2523

Neurovascular Catheters Market size was valued at USD 3.25 billion in 2023 and is poised to grow from USD 3.48 billion in 2024 to USD 6.08 billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

Market insights indicate robust growth in the neurovascular sector, driven by increasing incidences of neurological disorders such as brain aneurysms and strokes, alongside unhealthy lifestyle choices and heightened public awareness regarding treatment options. The global incidence of subarachnoid hemorrhage (SAH) stands at approximately 6.67 per 100,000 individuals, with over 500,000 affected annually, predominantly in low- and middle-income regions. Furthermore, technological advancements, particularly in neurovascular catheter technology, are set to fuel market expansion. Notably, CERENOVUS launched the EMBOGUARD catheter for endovascular procedures in February 2022, enhancing treatment efficacy for acute ischemic strokes. Research continues to affirm the safety and effectiveness of various neurovascular access methodologies, paving the way for innovative solutions and contributing to the anticipated market growth during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurovascular Catheters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurovascular Catheters Market Segments Analysis

Global Neurovascular Catheters Market is segmented by Type, Component, Application, End-use and region. Based on Type, the market is segmented into Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters and Others. Based on Component, the market is segmented into Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax and Other Components. Based on Application, the market is segmented into Embolic Stroke, Brain Aneurysm, Arteriovenous Malformations and Others. Based on End-use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurovascular Catheters Market

The growing incidence of neurological conditions, including strokes, aneurysms, and arteriovenous malformations (AVMs), significantly contributes to the rising demand for neurovascular catheters. These specialized catheters play a crucial role in both the diagnosis and treatment of such disorders. As the number of individuals affected by these neurological issues continues to rise, the need for effective intervention tools like neurovascular catheters becomes increasingly critical, thereby fueling market growth. This upward trend in neurological disorders underscores the essential nature of these medical devices and propels the demand for advancements and innovations within the neurovascular catheter market.

Restraints in the Neurovascular Catheters Market

The neurovascular catheters market faces significant challenges due to the potential complications associated with their use. Operating within the intricate network of blood vessels in the brain presents risks such as bleeding, clotting, vessel perforation, and infections. These complications can result in serious neurological impairments or, in extreme cases, fatalities. Additionally, they may prolong hospital stays and escalate healthcare expenses. Patients with pre-existing medical conditions are particularly susceptible to these risks, further complicating the clinical landscape. Consequently, such factors can act as restraints on the growth and adoption of neurovascular catheters in clinical practices.

Market Trends of the Neurovascular Catheters Market

The neurovascular catheters market is experiencing robust growth, propelled by the rising prevalence of neurological disorders such as strokes, aneurysms, and arteriovenous malformations. The World Health Organization (WHO) highlights that stroke ranks as the second leading cause of death worldwide, intensifying the urgency for advanced therapeutic solutions. An increasing aging population, coupled with greater awareness and diagnosis of neurological conditions, is further driving market demand. Innovations in catheter technology, including enhanced navigation and precision delivery systems, are also shaping the market landscape. Together, these dynamics position the neurovascular catheters market for substantial growth in the coming years, as healthcare providers seek effective interventions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Patent Analysis

Global Neurovascular Catheters Market Size by Type & CAGR (2025-2032)

Market Overview
Microcatheters
Balloon Catheters
Access Catheters
Embolization Catheters
Others

Global Neurovascular Catheters Market Size by Component & CAGR (2025-2032)

Market Overview
Catheter Mandrels
Catheter Liners
Reflow Heat Shrinks
Nylon Tubing/Pebax
Other Components

Global Neurovascular Catheters Market Size by Application & CAGR (2025-2032)

Market Overview
Embolic Stroke
Brain Aneurysm
Arteriovenous Malformations
Others

Global Neurovascular Catheters Market Size by End-use & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Centers

Global Neurovascular Catheters Market Size & CAGR (2025-2032)

North America (Type, Component, Application, End-use)
- US
- Canada
Europe (Type, Component, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Component, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Component, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Component, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Galway, Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (Marlborough, Massachusetts, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (Kalamazoo, Michigan, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra (Alameda, California, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences (Irvine, California, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Tokyo, Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (New Brunswick, New Jersey, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (Abbott Park, Illinois, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen (Melsungen, Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific (Shanghai, China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (Plano, Texas, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (Bloomington, Indiana, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (Dublin, Ohio, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew (London, United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (Wayne, Pennsylvania, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (South Jordan, Utah, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Osaka, Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc (Aichi, Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates (Newark, Delaware, USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Convatec (London, United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments